Search Results - Donald R. Branch

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia by Bonnie J.B. Lewis, Beth Binnington, Megan Blacquiere, Rolf Spirig, Fabian Käsermann, Donald R. Branch

    Published in eJHaem (2021-11-01)
    Get full text
    Article


  2. 2

    Synthesis and Biological Evaluation of Small Molecule Inhibitors of Immune Cytopenias by Melissa M. Lewis-Bakker, Ewa Wasilewski, Melika Loriamini, Shengyu Wang, Donald R. Branch, Lakshmi P. Kotra

    Published in ACS Omega (2025-07-01)
    Get full text
    Article


  3. 3

    Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection [v1; ref status: indexed, http://f1000r.es/51s] by Veljko Veljkovic, Philippe M. Loiseau, Bruno Figadere, Sanja Glisic, Nevena Veljkovic, Vladimir R. Perovic, David P. Cavanaugh, Donald R. Branch

    Published in F1000Research (2015-02-01)
    Get full text
    Article


  4. 4

    Small Molecule Drugs That Inhibit Phagocytosis by Melika Loriamini, Melissa M. Lewis-Bakker, Kayluz Frias Boligan, Siming Wang, Mairead B. Holton, Lakshmi P. Kotra, Donald R. Branch

    Published in Molecules (2023-01-01)
    Get full text
    Article


  5. 5

    Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy. by Milena Veljkovic, Violeta Dopsaj, Milivoj Dopsaj, Donald R Branch, Nevena Veljkovic, Maria M Sakarellos-Daitsiotis, Veljko Veljkovic, Sanja Glisic, Alfonso Colombatti

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  6. 6

    ABO blood groups influence macrophage-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes. by Kayla T Wolofsky, Kodjo Ayi, Donald R Branch, Annika K Hult, Martin L Olsson, W Conrad Liles, Christine M Cserti-Gazdewich, Kevin C Kain

    Published in PLoS Pathogens (2012-01-01)
    Get full text
    Article


  7. 7

    Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing. by Raymond W Wong, Ahalya Balachandran, Peter K Cheung, Ran Cheng, Qun Pan, Peter Stoilov, P Richard Harrigan, Benjamin J Blencowe, Donald R Branch, Alan Cochrane

    Published in PLoS Pathogens (2024-04-01)
    Get full text
    Article


  8. 8

    A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus. by Stephen D S McCarthy, Beata Majchrzak-Kita, Trina Racine, Hannah N Kozlowski, Darren P Baker, Thomas Hoenen, Gary P Kobinger, Eleanor N Fish, Donald R Branch

    Published in PLoS Neglected Tropical Diseases (2016-01-01)
    Get full text
    Article


  9. 9

    Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses by Audrey Kassardjian, Eric Sun, Jamie Sookhoo, Krithika Muthuraman, Kayluz Frias Boligan, Iga Kucharska, Edurne Rujas, Arif Jetha, Donald R. Branch, Shawn Babiuk, Brian Barber, Jean-Philippe Julien

    Published in Cell Reports (2023-04-01)
    Get full text
    Article


  10. 10

    THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets. by Lazaro Gil Gonzalez, Yuniel Fernandez-Marrero, Peter Alan Albert Norris, Zoya Tawhidi, Yuexin Shan, Yoelys Cruz-Leal, Kevin Doyoon Won, Kayluz Frias-Boligan, Donald R Branch, Alan H Lazarus

    Published in PLoS ONE (2022-01-01)
    Get full text
    Article


Search Tools: